Therapeutic and prophylactic thalidomide in TNBS-induced colitis: Synergistic effects on TNF-&alpha;, IL-12 and VEGF production

doi:10.3748/wjg.v13.i15.2166

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2242)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series.

Item

Count

PDF

271

HTML

1720

Figures (1-8)

244

Sum=2235

Apr 21, 2007 (publication date) through Dec 17, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Apr 21, 2007; 13(15): 2166-2173
Published online Apr 21, 2007. doi: 10.3748/wjg.v13.i15.2166

Full Size Figure Download Figure

Figure 1 HE staining of tissue obtained from the left colon of animals: untreated colitis (A), therapeutic-thalidomide (B), respectively. Sample from untreated colitis group shows gross ulceration and intense cellular infiltration, congestion and edema, while thalidomide-treated animal presents less inflammation and no ulceration (Original magnification × 100).

Citation: Carvalho AT, Souza H, Carneiro AJ, Castelo-Branco M, Madi K, Schanaider A, Silva F, Pereira Jứnior FA, Pereira MG, Tortori C, Dines I, Carvalho J, Rocha E, Elia C. Therapeutic and prophylactic thalidomide in TNBS-induced colitis: Synergistic effects on TNF-α, IL-12 and VEGF production. World J Gastroenterol 2007; 13(15): 2166-2173
URL: https://www.wjgnet.com/1007-9327/full/v13/i15/2166.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i15.2166